Cogent Biosciences, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Shareholders voted to elect the company's leadership; important for understanding who makes decisions.
Shows how much money the company made or lost; helps you track if business is improving.
Reports annual performance to help investors understand if the company grew or shrank last year.
Reports annual performance to help investors understand if the company grew or shrank last year.
Stocky reads Cogent Biosciences, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Cogent Biosciences, Inc.'s most recent tracked filing was a 8-K on 11 Jun 2026: Board directors elected at 2026 annual shareholder meeting.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.